The second most important purpose was to find out the role of innovative and creative way in promotion of new pharmaceutical product and its impact on their market value. Methodology: I went through questionnaire based survey on 10 medical representatives and 10 doctors respectively to find out ...
The FDA’s Breakthrough Therapy Designation (BTD) expedites patient access to innovative new treatments. While speeding up these processes can get new drugs to patients in need faster than they normally would through standard tracks, limited clinical evidence at la...
Yet such failures are bound to be out there, as they are for any pharmaceutical product. And when I turn to the research – sponsored stuff, admittedly – it shows that the story of the drug’s effectiveness can’t be told through personal accounts. It also reveals that for many men who...
Purpose Launching a new product successfully in a multi-brand portfolio is one of the major challenges a pharmaceutical marketer faces. This study aims to examine the role of detailing of new brands on physicians' prescription behaviour as compared to established brands. Further, the study explores...
Seeking competitive advantage in launching a pharmaceutical productfrom being the commodity that some in the industry feel it is, marketing research is a Segmentationtools help predict patient needs In the health care market, customer relationship 4662 Slater Road,Eagan, MN 55122 651-379-6200 ...
The article reports on the claim by Sanofi chief executive officer (CEO) Christopher Viehbacher that the pharmaceutical company is in good financial condition despite releasing unchanged or low earnings forecast for 2013. Viehbacher states that the expiration of the patent for its drug Plavix has no...
The exploration is a great effort to overcome the shortcomings of traditional new product marketing mode. Most important of all, it may become a prevalent solution for the development of Chinese national pharmaceutical enterprises.Ding JianTianjin Tasly Medicine Distribution G...
In spite of rising R&D expenditure the industry has to cope with a shrinking number of new pharmaceutical ingredients. This gap in the pipeline is by necessity shifting the focus to exploiting the full potential of the existing product portfolio, including off patent products. Marketing strategies ...
Western Mail (Cardiff, Wales)